Armata Pharmaceuticals Profit Margin

Armata Pharmaceuticals (ARMP) currently reports a profit margin of -4383.62% as of June 2026. That compares with -755.2% in the prior-year period — down 480.5% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Armata Pharmaceuticals's profit margin history and peer comparisons.

Armata Pharmaceuticals's profit margin decreased from -755.2% to -4383.62% — a 480.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Armata Pharmaceuticals's profit margin of -4383.62% is lower than the Healthcare sector average of 21.34%. That is roughly 20646.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Armata Pharmaceuticals's current -4383.62% should be judged against Healthcare norms (sector average: 21.34%) and against ARMP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -4383.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Armata Pharmaceuticals, and consider following ARMP for alerts when major investors trade the stock.